【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 15
2 Introduction 16
2.1 Aesthetic Devices Overview 16
3 Products under Development 17
3.1 Aesthetic Devices – Pipeline Products by Stage of Development 17
3.2 Aesthetic Devices – Pipeline Products by Segment 18
3.3 Aesthetic Devices – Pipeline Products by Territory 19
3.4 Aesthetic Devices – Pipeline Products by Regulatory Path 21
3.5 Aesthetic Devices – Pipeline Products by Estimated Approval Date 22
3.6 Aesthetic Devices – Ongoing Clinical Trials 23
4 Aesthetic Devices – Pipeline Products under Development by Companies 24
4.1 Aesthetic Devices Companies – Pipeline Products by Stage of Development 24
4.2 Aesthetic Devices – Pipeline Products by Stage of Development 27
5 Aesthetic Devices Companies and Product Overview 32
5.1 Advalight Company Overview 32
5.1.1 Advalight Pipeline Products & Ongoing Clinical Trials Overview 32
5.2 Aesthetic Medical Device Company Overview 33
5.2.1 Aesthetic Medical Device Pipeline Products & Ongoing Clinical Trials Overview 33
5.3 Aesthetics Point Ltd. Company Overview 35
5.3.1 Aesthetics Point Ltd. Pipeline Products & Ongoing Clinical Trials Overview 35
5.4 AirXpanders, Inc. Company Overview 36
5.4.1 AirXpanders, Inc. Pipeline Products & Ongoing Clinical Trials Overview 36
5.5 Allergan, Inc. Company Overview 40
5.5.1 Allergan, Inc. Pipeline Products & Ongoing Clinical Trials Overview 40
5.6 Ambicare Health Ltd Company Overview 49
5.6.1 Ambicare Health Ltd Pipeline Products & Ongoing Clinical Trials Overview 49
5.7 Andrew Technology, LLC Company Overview 52
5.7.1 Andrew Technology, LLC Pipeline Products & Ongoing Clinical Trials Overview 52
5.8 Anika Therapeutics, Inc. Company Overview 53
5.8.1 Anika Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 53
5.9 Avita Medical Ltd Company Overview 55
5.9.1 Avita Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 55
5.10 BioPhotas, Inc. Company Overview 60
5.10.1 BioPhotas, Inc. Pipeline Products & Ongoing Clinical Trials Overview 60
5.11 BioPolymer GmbH & Co. KG Company Overview 62
5.11.1 BioPolymer GmbH & Co. KG Pipeline Products & Ongoing Clinical Trials Overview 62
5.12 Biosculpture Technology, Inc. Company Overview 66
5.12.1 Biosculpture Technology, Inc. Pipeline Products & Ongoing Clinical Trials Overview 66
5.13 Body Organ Biomedical Corp. Company Overview 68
5.13.1 Body Organ Biomedical Corp. Pipeline Products & Ongoing Clinical Trials Overview 68
5.14 Chromogenex Technologies Limited Company Overview 70
5.14.1 Chromogenex Technologies Limited Pipeline Products & Ongoing Clinical Trials Overview 70
5.15 Cozart plc Company Overview 71
5.15.1 Cozart plc Pipeline Products & Ongoing Clinical Trials Overview 71
5.16 Cynosure, Inc. Company Overview 72
5.16.1 Cynosure, Inc. Pipeline Products & Ongoing Clinical Trials Overview 72
5.17 Cytophil, Inc. Company Overview 80
5.17.1 Cytophil, Inc. Pipeline Products & Ongoing Clinical Trials Overview 80
5.18 Cytori Therapeutics, Inc. Company Overview 81
5.18.1 Cytori Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 81
5.19 Cytosial Biomedic, S.a.s. Company Overview 84
5.19.1 Cytosial Biomedic, S.a.s. Pipeline Products & Ongoing Clinical Trials Overview 84
5.20 Dermele Skin Care, LLC Company Overview 86
5.20.1 Dermele Skin Care, LLC Pipeline Products & Ongoing Clinical Trials Overview 86
5.21 Ellman International, Inc. Company Overview 87
5.21.1 Ellman International, Inc. Pipeline Products & Ongoing Clinical Trials Overview 87
5.22 Erchonia Corporation Company Overview 88
5.22.1 Erchonia Corporation Pipeline Products & Ongoing Clinical Trials Overview 88
5.23 Eternity Healthcare Inc. Company Overview 90
5.23.1 Eternity Healthcare Inc. Pipeline Products & Ongoing Clinical Trials Overview 90
5.24 EternoGen, LLC Company Overview 91
5.24.1 EternoGen, LLC Pipeline Products & Ongoing Clinical Trials Overview 91
5.25 Eve Aesthetics Ltd. Company Overview 92
5.25.1 Eve Aesthetics Ltd. Pipeline Products & Ongoing Clinical Trials Overview 92
5.26 FibroGen, Inc. Company Overview 93
5.26.1 FibroGen, Inc. Pipeline Products & Ongoing Clinical Trials Overview 93
5.27 Forticell Bioscience, Inc. Company Overview 95
5.27.1 Forticell Bioscience, Inc. Pipeline Products & Ongoing Clinical Trials Overview 95
5.28 Genethia Phrima SRL Company Overview 96
5.28.1 Genethia Phrima SRL Pipeline Products & Ongoing Clinical Trials Overview 96
5.29 Genzyme Corporation Company Overview 97
5.29.1 Genzyme Corporation Pipeline Products & Ongoing Clinical Trials Overview 97
5.30 Ilooda Co., Ltd. Company Overview 98
5.30.1 Ilooda Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 98
5.31 ImpLite Ltd. Company Overview 99
5.31.1 ImpLite Ltd. Pipeline Products & Ongoing Clinical Trials Overview 99
5.32 Innovia LLC Company Overview 100
5.32.1 Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 100
5.33 Invasix Company Overview 102
5.33.1 Invasix Pipeline Products & Ongoing Clinical Trials Overview 102
5.34 Juvenis Ltd. Company Overview 106
5.34.1 Juvenis Ltd. Pipeline Products & Ongoing Clinical Trials Overview 106
5.35 Keraderm LLC Company Overview 107
5.35.1 Keraderm LLC Pipeline Products & Ongoing Clinical Trials Overview 107
5.36 Khorionyx Company Overview 109
5.36.1 Khorionyx Pipeline Products & Ongoing Clinical Trials Overview 109
5.37 L&C Bio Company Overview 110
5.37.1 L&C Bio Pipeline Products & Ongoing Clinical Trials Overview 110
5.38 Medifirst Solutions, Inc. Company Overview 111
5.38.1 Medifirst Solutions, Inc. Pipeline Products & Ongoing Clinical Trials Overview 111
5.39 Medixsysteme Company Overview 113
5.39.1 Medixsysteme Pipeline Products & Ongoing Clinical Trials Overview 113
5.40 Mentor Worldwide LLC Company Overview 117
5.40.1 Mentor Worldwide LLC Pipeline Products & Ongoing Clinical Trials Overview 117
5.41 Merz Pharma GmbH & Co. KgaA Company Overview 119
5.41.1 Merz Pharma GmbH & Co. KgaA Pipeline Products & Ongoing Clinical Trials Overview 119
5.42 Moma Therapeutics, Inc. Company Overview 121
5.42.1 Moma Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 121
5.43 Mosaic Medical Technologies, Inc Company Overview 122
5.43.1 Mosaic Medical Technologies, Inc Pipeline Products & Ongoing Clinical Trials Overview 122
5.44 Neosthetic, LLC Company Overview 123
5.44.1 Neosthetic, LLC Pipeline Products & Ongoing Clinical Trials Overview 123
5.45 NivaSonix, LLC Company Overview 124
5.45.1 NivaSonix, LLC Pipeline Products & Ongoing Clinical Trials Overview 124
5.46 Northwestern University Company Overview 125
5.46.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 125
5.47 Northwood Medical Innovation Limited Company Overview 126
5.47.1 Northwood Medical Innovation Limited Pipeline Products & Ongoing Clinical Trials Overview 126
5.48 Nu Skin International Inc. Company Overview 127
5.48.1 Nu Skin International Inc. Pipeline Products & Ongoing Clinical Trials Overview 127
5.49 Oligo Medic, Inc. Company Overview 129
5.49.1 Oligo Medic, Inc. Pipeline Products & Ongoing Clinical Trials Overview 129
5.50 ORGEV Laboratories Company Overview 130
5.50.1 ORGEV Laboratories Pipeline Products & Ongoing Clinical Trials Overview 130
5.51 Osyris Medical Company Overview 144
5.51.1 Osyris Medical Pipeline Products & Ongoing Clinical Trials Overview 144
5.52 Philips Healthcare Company Overview 145
5.52.1 Philips Healthcare Pipeline Products & Ongoing Clinical Trials Overview 145
5.53 PhotoDerma SA Company Overview 147
5.53.1 PhotoDerma SA Pipeline Products & Ongoing Clinical Trials Overview 147
5.54 PhotoMedex, Inc. Company Overview 149
5.54.1 PhotoMedex, Inc. Pipeline Products & Ongoing Clinical Trials Overview 149
5.55 Pinnacle Therapeutics Company Overview 152
5.55.1 Pinnacle Therapeutics Pipeline Products & Ongoing Clinical Trials Overview 152
5.56 PolyNovo Biomaterials Pty Ltd Company Overview 153
5.56.1 PolyNovo Biomaterials Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 153
5.57 PS Advanced Engineering Company Overview 155
5.57.1 PS Advanced Engineering Pipeline Products & Ongoing Clinical Trials Overview 155
5.58 Rocky Mountain Biosystems Inc Company Overview 159
5.58.1 Rocky Mountain Biosystems Inc Pipeline Products & Ongoing Clinical Trials Overview 159
5.59 SANUWAVE Health, Inc. Company Overview 160
5.59.1 SANUWAVE Health, Inc. Pipeline Products & Ongoing Clinical Trials Overview 160
5.60 Sebacia Inc. Company Overview 163
5.60.1 Sebacia Inc. Pipeline Products & Ongoing Clinical Trials Overview 163
5.61 Sekisui Medical Co., Ltd. Company Overview 166
5.61.1 Sekisui Medical Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 166
5.62 SharpLight Company Overview 167
5.62.1 SharpLight Pipeline Products & Ongoing Clinical Trials Overview 167
5.63 Shin Poong Pharm.Co., Ltd. Company Overview 170
5.63.1 Shin Poong Pharm.Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 170
5.64 Sinclair IS Pharma Plc Company Overview 171
5.64.1 Sinclair IS Pharma Plc Pipeline Products & Ongoing Clinical Trials Overview 171
5.65 Slender Medical Ltd. Company Overview 183
5.65.1 Slender Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 183
5.66 Suneva Medical, Inc. Company Overview 184
5.66.1 Suneva Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 184
5.67 Sybaritic, Inc. Company Overview 188
5.67.1 Sybaritic, Inc. Pipeline Products & Ongoing Clinical Trials Overview 188
5.68 Syneron Medical Ltd. Company Overview 191
5.68.1 Syneron Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 191
5.69 TEI Biosciences, Inc. Company Overview 196
5.69.1 TEI Biosciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 196
5.70 ThermiAesthetics Company Overview 197
5.70.1 ThermiAesthetics Pipeline Products & Ongoing Clinical Trials Overview 197
5.71 University of California, Irvine Company Overview 199
5.71.1 University of California, Irvine Pipeline Products & Ongoing Clinical Trials Overview 199
5.72 Valeant Pharmaceuticals Ltd Company Overview 200
5.72.1 Valeant Pharmaceuticals Ltd Pipeline Products & Ongoing Clinical Trials Overview 200
5.73 Yolo Medical Inc. Company Overview 201
5.73.1 Yolo Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 201
6 Aesthetic Devices- Recent Developments 203
7 Appendix 310
7.1 Methodology 310
7.2 About GlobalData 312
7.3 Contact Us 313
7.4 Disclaimer 313
【レポート販売概要】
■ タイトル：世界の美容機器開発動向：医療機器パイプライン分析2015■ 英文：Aesthetic Devices - Medical Devices Pipeline Assessment, 2015
■ 発行日：2016年1月5日
■ 調査会社：GlobalData
■ 商品コード：GDME0145EPD
■ 調査対象地域：グローバル
- Onglyza (Type 2 Diabetes)：市場予測と分析（～2022）Onglyza (Type 2 Diabetes) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new report, “Onglyza (Type 2 Diabetes) - Forecast and Market Analysis to 2022”. The type 2 diabetes market is mature and crowded with inexpensive generics. Despite being marked by a late-stage pipeline filled with me-too drugs, this market will undergo substantial growth between 2012 and 2022, more …
- 建設用化学製品の世界市場：コンクリート混和材、建設用接着剤、建設用シーラント、難燃剤The construction chemicals market is estimated to reach USD 33.98 Billion in terms of volume by 2020, signifying a high CAGR of over 7.62% between 2015 and 2020. The construction chemicals market registered a high growth in the past few years which is estimated to continue in the coming years supported by growing construction industry in Asia-pacific and RoW regions. The demand for construction ch …
- ICT予算及び人員配置動向：金融産業部門 – 企業のICT投資計画Why was the report written? In order to provide a depth of insight into ICT vendors’ and service providers’ potential customers. What is the current market landscape and what is changing? Although financial institutions are allocating a large proportion of their ICT budgets to software licenses, enterprises are gradually shifting their focus towards software as a service (SaaS) as well. What are t …
- Total S.A.社の石油・ガス開発・生産動向及びコスト分析（2013年第4四半期）Total S.A. Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2013 Summary Total S.A. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key operational d …
- 硝酸カリウムの世界市場動向The report presents detailed overview of the Potassium Nitrate market in the world and regions (CIS countries in particular) by contemplating and analyzing its various parameters. Firstly, brief introduction is provided. Thus, Potassium Nitrate properties, application areas and manufacturing technologies are considered. Further goes the analysis of global Potassium Nitrate market with emphasis on …
- レディーミックスコンクリートの世界市場2019-2023Global Ready-mix Concrete Market: About this market Ready-mix concrete is a construction material manufactured in a factory or a plant within specific guidelines such as 3 parts aggregates, 2 parts water, and 1-part cement. Technavio’s ready-mix concrete market analysis considers sales from both non-residential and residential. Our analysis also considers the sales of ready-mix concrete in APAC, E …
- プレイアウト自動化の世界市場2016-2020About Playout Automation Playout automation is a technology that integrates all the devices involved in a playout chain (such as video routers, switchers, audio servers, channel branding processors, and graphic inserts) in a single device. Playout automation takes control of multiple devices involved in a playout chain, whereas integrated playout automation uses a single device to perform the func …
- 高度教育用金融・HRMソフトウェアの世界市場2016-2020About the Higher Education Financial and HRM Software Market The global higher education financial and HRM software market consists of software solutions that are employed by institutions to improve the decision-making and productivity of employees and management of financial resources. The data collected from the software is further analyzed using analytics applications. The analysis is to ensure …
- ポリフェニレンサルファイド（PPS）の世界市場：地域別、アプリケーション別（コーティング剤、自動車、電気・電子、工業）、セグメント予測The global polyphenylene sulfide market size is expected to reach at USD 2.14 billion by 2025 expanding at a CAGR of 8.8%, according to a new report by Grand View Research, Inc. Several characteristics including high chemical and creep resistance, excellent stiffness and strength, and temperature properties of PPS are the key factors diving their demand. Automotive is projected to be the largest a …
- Petron Corporation：石油・ガスバリューチェーン分析レポート2013Petron Corporation Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Petron Corporation" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Petron Corporation”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The report examines t …
- レブリン酸の世界市場予測（～2021）： 可塑剤、医薬品＆化粧品The levulinic acid market is projected to reach USD 32.5 Million by 2021, at a CAGR of 14.0% between 2016 and 2021. The key factor fueling the growth of the levulinic acid market is the increasing demand for levulinic acid from plasticizers, pharmaceuticals, and cosmetic industries. Levulinic acid is used in anti–inflammatory medication, and mineral supplements in pharmaceutical applications. Majo …
- エアスタータの世界市場：ベーンエアスタータ、タービンエアスタータGlobal Air starter market is projected to reach a size of USD 397.0 Million by 2021, at a CAGR of 3.8% from 2016 to 2021. Compatibility to explosive and potentially hazardous environments and compact size of the device are the main driving factors. The report segments the air starter market on the basis of major end-user industries into oil & gas, aviation, mining, marine, and others. The aviation …
- バッグの世界市場2017-2021：トラベルバッグ、カジュアルバッグ、ビジネスバッグAbout LuggageLuggage and related luggage products are increasingly moving away from having only utilitarian value to functioning as fashion accessories. Luggage products have been gaining consumer interest with the growing popularity of outdoor sports and adventure travel, apart from a rise in the global travel industry. The market is expected to witness growing demand for durable luggage products …
- 地盤工学用計装・モニタリングの世界市場予測（～2022年）The geotechnical instrumentation and monitoring market is estimated to reach USD 4.64 Billion by 2022, growing at a CAGR of 11.37% between 2017 and 2022. The growth of the market is attributed to the increasing infrastructural investment across various countries all over the world, catastrophic failure of structures resulting in loss of lives, stringent environmental regulations pertaining to the …
- Acne Vulgaris：グローバル臨床試験レビューH2, 2013Acne Vulgaris Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Acne Vulgaris Global Clinical Trials Review, H2, 2013" provides data on the Acne Vulgaris clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Acne Vulgaris. It includes an overview of the trial numbers and their recruitment status as per the …
